Mandate

Vinge advises Eleda’s shareholders in connection with partnership with Altor

Vinge has advised the shareholders of Eleda Infra Services Group (“Eleda”) on the divestment of a majority stake in Eleda to Altor Fund V.

As part of the transaction, Eleda acquires and partners with the entrepreneurs of Järfälla VA- & Byggentreprenad AB and divests KEWAB, Kenneth Wahlström Aktiebolag. In addition, Eleda acquires ONE Nordic from Altor Fund III. Management of the respective companies will remain as significant shareholders of the combined group and continue in their respective operational management roles.

The new, larger, Eleda will be an expansive infrastructure services group focusing on small to medium sized civil engineering and transmission infrastructure projects and services across a wide range of sectors including water works, road works, energy works and data centers.  The companies have an impressive history of strong growth and a proven ability to gain additional market shares in fast-growing areas of the market. The new Eleda group had a combined turnover of ca SEK 6 billion in 2019.

The transaction is subject to customary regulatory approvals.

Vinge’s team consisted of partner Christina Kokko together with associates Manne Bergström, Michaela Cronemyr, Johanna Wiberg, Fredric Reissmüller, Hanna Risberg, Stina Bengtsson and Jonathan Riddersholm (M&A), Trine Osen Bergqvist, Xandra Ståhlberg and Lisa Malmborg (Competition), Josefine Lanker (Banking and Finance), Jessica Öijer and Christoffer Widström (VDR Specialists) and Nathalie Hughes (VDR Assistant).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026